首页> 美国卫生研究院文献>Mayo Clinic Proceedings >Population Screening for Barrett Esophagus: A Prospective Randomized Pilot Study
【2h】

Population Screening for Barrett Esophagus: A Prospective Randomized Pilot Study

机译:巴雷特食管的人口筛查:前瞻性随机试验研究。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

OBJECTIVE: >To assess the feasibility of unsedated transnasal endoscopy (uTNE) and video capsule endoscopy (VCE) as alternatives to sedated endoscopy (sEGD) as screening tools for Barrett esophagus (BE) and to obtain preliminary estimates of participation rates for sEGD, uTNE, and VCE when used for community BE screening in a population cohort.PATIENTS AND METHODS: >From February 1, 2009, to May 31, 2010, patients from Olmsted County, Minnesota, who were older than 50 years and had no history of known BE were randomized (stratified by age, sex, reflux symptoms noted in a validated questionnaire) into 3 groups for esophageal evaluation with sEGD, uTNE, or VCE. Participation rates and safety profiles were estimated.RESULTS: >We contacted 127 patients to recruit 20 for each procedure arm (60 total). The probability of participation was 38% (95% confidence interval [CI], 26%-51%) for sEGD, 50% (95% CI, 35%-65%) for uTNE, and 59% (95% CI, 42%-74%) for VCE. Both uTNE and VCE were well tolerated without adverse effects. BE was identified in 3 patients and esophagitis in 8.CONCLUSION: >Unsedated techniques may be acceptable, feasible, and safe alternatives to sEGD to screen for BE in the community.>Trial Registration: clinicaltrials.gov identifier:
机译:目的:>评估未镇静的经鼻内镜(uTNE)和视频胶囊内窥镜(VCE)替代镇静内窥镜(sEGD)作为Barrett食管(BE)的筛查工具的可行性,并初步评估sEGD的参与率,uTNE和VCE在人群队列中用于社区BE筛查。患者和方法:>从2009年2月1日到2010年5月31日,明尼苏达州Olmsted县的患者年龄大于将50岁且无已知BE病史的患者随机分为3组(按年龄,性别,经验证的问卷中注明的反流症状分类),以sEGD,uTNE或VCE进行食道评估。估计参与率和安全性。结果:>我们与127名患者进行了联系,为每个手术组招募20名患者(共60名)。 sEGD的参与概率为38%(95%置信区间[CI],26%-51%),uTNE的参与概率为50%(95%CI,35%-65%),59%(95%CI,42) %-74%)。 uTNE和VCE均耐受良好,且无不良影响。在3例患者中发现了BE,在8例中发现了食管炎。结论:>未镇静的技术可以替代sEGD在社区中进行BE筛查。 >试验注册: Clinicaltrials.gov标识符:

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号